As we turned the page on 2020, COVID-19 vaccines began to be rolled out while fiscal taps are flooding the economy with cash, notably in Canada and the U.S.
After a challenging 2020, we are optimistic 2021 will be much better although it may take a few months to get the pieces in place for a pronounced recovery.
Vaccine developments have opened the door to market rotation toward cyclicals and value.
Removal of U.S. political uncertainty and positive news on a COVID-19 vaccine should ensure a robust economic and earnings recovery in 2021 even though mobility is likely to be restrained this winter.
Election night clarity was probably too much to hope for.
Given the current structure of the race, a Democratic presidency looks likely, coupled with a very slight Democratic edge in the Senate.
Election uncertainty, while still elevated, has improved.
Global equities registered a disappointing performance in September, but the macro news confirmed the recovery was well underway and lost ground is being recovered relatively fast.
Many countries and regions are seeing a resurgence of COVID cases, bringing back mobility restrictions.
While the ebb and flow of the high-flying tech stocks is to be expected, some underlying trends are profoundly anchoring the longer-term outlook.
The economic recovery is about halfway through, but we already have a good idea of the lasting societal changes emerging from the pandemic.
While a vaccine might be on its way later this year, social distancing and mobility restrictions have inflicted severe pain on some sectors of the economy.
BMO Investments Inc., the manager of BMO LifeStage Plus 2020 Fund and BMO Target Education 2020 Portfolio (collectively, the "Terminating Funds") today announced that these funds are approaching their June 30, 2020 target end date.
For Mutual Funds:1-800-668-7327
Let us contact youHave a representative contact you at your convenience